, Volume 166, Issue 2, pp 127–138 | Cite as

Distinctive effects of modafinil and d-amphetamine on the homeostatic and circadian modulation of the human waking EEG

  • Florian Chapotot
  • Ross Pigeau
  • Frédéric Canini
  • Lionel Bourdon
  • Alain Buguet
Original Investigation



Modafinil is a wake-promoting agent that affects hypothalamic structures involved in the homeostatic and circadian regulation of vigilance. Administered during sleep deprivation, it reduces the need for prolonged recovery sleep and decreases the rebound in EEG slow-wave activity. These diachronic effects suggest an action of modafinil on a homeostatic sleep regulatory process.


The aim of this study was to determine whether modafinil, in comparison to the d-amphetamine reference psychostimulant and to placebo, interferes with the vigilance regulatory processes reflected in the EEG during waking.


Thirty-three healthy subjects were investigated during 60 h of sustained wakefulness in a double-blind placebo-controlled parallel-design study. A 4-min maintenance-of-wakefulness test administered hourly allowed the concomitant assessment of alertness and waking EEG activity. The effects of equipotent psychostimulant dosages (modafinil 300 mg and d-amphetamine 20 mg) were evaluated at the beginning of the first sleep deprivation night, at the end of the second sleep deprivation night and in the afternoon preceding the first recovery night.


One hour following ingestion, both psychostimulants increased alertness during 10–12 h, independently of the time of administration. At the level of the waking EEG, d-amphetamine attenuated the natural circadian rhythm of the different frequency bands and suppressed the sleep deprivation-related increase in low frequency (0.5–7 Hz) powers. In contrast, modafinil, which exhibited a transient amphetamine-like effect, had slight effect on circadian rhythms. Its selective action was characterized by maintenance of the α1 (8.5–11.5 Hz) EEG power, which under placebo exhibited a homeostatic decrease paralleling that of alertness with a circadian trough at night.


These findings demonstrate that the alertness-promoting effects of modafinil and d-amphetamine involve distinct EEG activities and do not reside on the same vigilance regulatory processes. While d-amphetamine inhibits the expression of a sleep-related process, probably through a direct cortical activation masking EEG circadian rhythms, modafinil, through a synchronic effect, preferentially disrupts the homeostatic down-regulation of a waking drive.


Alertness Circadian rhythm Homeostasis Sleep deprivation Psychostimulant Waking EEG 



This study was supported by grants from Institut Electricité Santé, partner of the electricity profession, Laboratoire L. Lafon and from grant no. 9810070 DGA/DSP/STTC/DT-FH of the French Ministry of Defense. We are grateful to John Bowen, Yolande Coudurier, Nadine Fidier, Andrea Hawton, Alain Montmayeur, Patty Odell, Angela Ricci, Alain Roux, and Tim Pointing for valuable assistance. We are indebted to Captain Kirk Evoy who coordinated the selection of Canadian Forces volunteers, and to Dr. David Salisbury for providing medical assistance.


  1. Aeschbach D, Matthews JR, Postolache TT, Jackson MA, Giesen HA, Wehr TA (1997) Dynamics of the human EEG during prolonged wakefulness: evidence for frequency-specific circadian and homeostatic influences. Neurosci Lett 239:121–124CrossRefPubMedGoogle Scholar
  2. Aeschbach D, Matthews JR, Postolache TT, Jackson MA, Giesen HA, Wehr TA (1999) Two circadian rhythms in the human electroencephalogram during wakefulness. Am J Physiol 277:R1771–R1779PubMedGoogle Scholar
  3. Akerstedt T, Folkard S (1996) Predicting sleep latency from the three-process model of alertness regulation. Psychophysiology 33:385–389PubMedGoogle Scholar
  4. Akerstedt T, Gillberg M (1990) Subjective and objective sleepiness in the active individual. Int J Neurosci 52:29–37PubMedGoogle Scholar
  5. American Electroencephalographic Society (1991) Guidelines for standard electrode position nomenclature. J Clin Neurophysiol 8:200–202PubMedGoogle Scholar
  6. Angus RG, Pigeau RA, Heslegrave RJ (1992) Sustained operations studies: from the field to the laboratory. In: Stampi C (ed) Why we nap. Birkhauser, BostonGoogle Scholar
  7. Aston-Jones G, Bloom FE (1981) Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1:876–886PubMedGoogle Scholar
  8. Baranski JV, Pigeau RA (1997) Self-monitoring cognitive performance during sleep deprivation: effects of modafinil, d-amphetamine and placebo. J Sleep Res 6:84–91PubMedGoogle Scholar
  9. Bastuji H, Jouvet M (1988) Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog Neuropsychopharmacol Biol Psychiatry 12:695–700PubMedGoogle Scholar
  10. Berridge CW, O'Neil J, Wifler K (1999) Amphetamine acts within the medial basal forebrain to initiate and maintain alert waking. Neuroscience 93:885–896CrossRefPubMedGoogle Scholar
  11. Besset A, Tafti M, Villemin E, Billiard M (1993) The effects of modafinil (300 mg) on sleep, sleepiness and arousal in narcoleptic patients. Neurophysiol Clin 23:47–60PubMedGoogle Scholar
  12. Billiard M, Besset A, Montplaisir J, Laffont F, Goldenberg F, Weill JS, Lubin S (1994) Modafinil: a double-blind multicentric study. Sleep 17:S107–S112PubMedGoogle Scholar
  13. Borbély AA (1982) A two process model of sleep regulation. Hum Neurobiol 1:195–204PubMedGoogle Scholar
  14. Broughton RJ, Fleming JA, George CF, Hill JD, Kryger MH, Moldofsky H, Montplaisir JY, Morehouse RL, Moscovitch A, Murphy WF (1997) Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology 49:444–451PubMedGoogle Scholar
  15. Brunner DP, Vasko RC, Detka CS, Monahan JP, Reynolds CF, Kupfer DJ (1996) Muscle artifacts in the sleep EEG: automated detection and effect on all-night EEG power spectra. J Sleep Res 5:155–164PubMedGoogle Scholar
  16. Buguet A, Montmayeur A, Pigeau RA, Naitoh P (1995) Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. Effects on two nights of recovery sleep. J Sleep Res 4:229–241PubMedGoogle Scholar
  17. Cajochen C, Brunner DP, Krauchi K, Graw P, ustice A (1995) Power density in theta/alpha frequencies of the waking EEG progressively increases during sustained wakefulness. Sleep 18:890–894PubMedGoogle Scholar
  18. Cajochen C, Brunner DP, Krauchi K, Graw P, Wirz-Justice A (2000) EEG and subjective sleepiness during extended wakefulness in seasonal affective disorder: circadian and homeostatic influences. Biol Psychiatry 47:610–617CrossRefPubMedGoogle Scholar
  19. Cajochen C, Knoblauch V, Krauchi K, Renz C, Wirz-Justice A (2001) Dynamics of frontal EEG activity, sleepiness and body temperature under high and low sleep pressure. Neuroreport 12:2277–2281PubMedGoogle Scholar
  20. Caldwell JA, Caldwell JL, Smythe NK, Hall KK (2000) A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study. Psychopharmacology 150:272–282CrossRefPubMedGoogle Scholar
  21. Carskadon MA, Dement WC (1992) Multiple sleep latency tests during the constant routine. Sleep 15:396–399PubMedGoogle Scholar
  22. Chapotot F, Jouny C, Muzet A, Buguet A, Brandenberger G (2000) High frequency waking EEG: reflection of a slow ultradion rhythm in daytime arousal. Neuroreport 11:2223–2227PubMedGoogle Scholar
  23. Cooley JW, Tuckey JW (1965) An algorithm for the machine calculation of complex Fourier series. Math Comp 19:297–301Google Scholar
  24. Corsi-Cabrera M, Ramos J, Arce C, Guevara MA, Ponce-de-Léon M, Lorenzo I (1992) Changes in the waking EEG as a consequence of sleep and sleep deprivation. Sleep 15:550–555PubMedGoogle Scholar
  25. de Saint Hilaire Z, Orosco M, Rouch C, Blanc G, Nicolaidis S (2001) Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats. Neuroreport 12:3533–3537PubMedGoogle Scholar
  26. Dumont M, Macchi MM, Carrier J, Lafrance C, Hébert M (1999) Time course of narrow frequency bands in the waking EEG during sleep deprivation. Neuroreport 10:403–407PubMedGoogle Scholar
  27. Edgar DM, Seidel WF (1997) Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat. J Pharmacol Exp Ther 283:757–769PubMedGoogle Scholar
  28. Ferraro L, Tanganelli S, O'Connor WT, Antonelli T, Rambert F, Fuxe K (1996) The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor. Neurosci Lett 220:5–8PubMedGoogle Scholar
  29. Ferraro L, Antonelli T, O'Connor WT, Tanganelli S, Rambert FA, Fuxe K (1997) Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers. Biol Psychiatry 42:1181–1183PubMedGoogle Scholar
  30. Ferraro L, Antonelli T, Tanganelli S, O'Connor WT, Perez de la Mora M, Mendez-Franco J, Rambert F, Fuxe K (1999) The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade. Neuropsychopharmacology 20:346–356CrossRefPubMedGoogle Scholar
  31. Fink M (1978) EEG and psychopharmacology. Electroencephalogr Clin Neurophysiol Suppl 34:41–56PubMedGoogle Scholar
  32. Fry JM (1998) Treatment modalities for narcolepsy. Neurology 50:S43–S48PubMedGoogle Scholar
  33. Krueger JM, Obal FJ, Fang J (1999) Why we sleep: a theoretical view of sleep function. Sleep Med Rev 3:119–129Google Scholar
  34. Laboratoire Lafon L (1997) Modiodal, modafinil. Dossier d'information médicale et pharmaceutique. Laboratoire L. Lafon, Maison-Alfort, FranceGoogle Scholar
  35. Laffont F, Mayer G, Minz M (1994) Modafinil in diurnal sleepiness. A study of 123 patients. Sleep 17:S113–S115PubMedGoogle Scholar
  36. Lagarde D, Batejat D, Van Beers P, Sarafian D, Pradella S (1995) Interest of modafinil, a new psychostimulant, during a sixty-hour sleep deprivation experiment. Fundam Clin Pharmacol 9:271–279PubMedGoogle Scholar
  37. Lin JS, Hou Y, Jouvet M (1996) Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci USA 93:14128–14133Google Scholar
  38. Lin JS, Gervasoni D, Hou Y, Vanni-Mercier G, Rambert F, Frydman A, Jouvet M (2000) Effects of amphetamine and modafinil on the sleep/wake cycle during experimental hypersomnia induced by sleep deprivation in the cat. J Sleep Res 9:89–96PubMedGoogle Scholar
  39. Lopes da Silva FH, Vos JE, Mooibroek J, Van Rotterdam A (1980) Relative contributions of intracortical and thalamo-cortical processes in the generation of alpha rhythms revealed by partial coherence analysis. Electroencephalogr Clin Neurophysiol 50:449–456PubMedGoogle Scholar
  40. Lorenzo I, Ramos J, Arce C, Guevara MA, Corsi-Cabrera M (1995) Effect of total sleep deprivation on reaction time and waking EEG activity in man. Sleep 18:346–354PubMedGoogle Scholar
  41. Matejcek M (1982) Vigilance and the EEG: psychological, physiological and pharmacological aspects. Electroencephalography in drug research. Fischer, Stuttgart New York, pp 405–440Google Scholar
  42. Mignot E, Nishino S, Guilleminault C, Dement WC (1994) Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep 17:436–437PubMedGoogle Scholar
  43. Mitler MM, Gujavarty KS, Browman CP (1982) Maintenance of wakefulness test : a polysomnographic technique for evaluating treatment efficacy in patients with excessive somnolence. Electroencephalogr Clin Neurophysiol 53:658–661Google Scholar
  44. Nicholson AN, Stone BM (1980) Heterocyclic amphetamine and caffeine on sleep in man. Br J Clin Pharmacol 9:195–203PubMedGoogle Scholar
  45. Nishino S, Mao J, Sampahkumaran R, Shelton J, Mignot E (1998) Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants. Sleep Res Online 49:49–61Google Scholar
  46. Perez de la Mora M, Aguilar-Garcia A, Ramon-Frias T, Ramirez-Ramirez R, Mendez-Franco J, Rambert F, Fuxe K (1999) Effects of the vigilance promoting drug modafinil on the synthesis of GABA and glutamate in slices of rat hypothalamus. Neurosci Lett 259:181–185CrossRefPubMedGoogle Scholar
  47. Pigeau RA, Naitoh P, Buguet A, McCann C, Baranski J, Taylor M, Thompson M, Mack I (1995) Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. Effects on mood, fatigue, cognitive performance and body temperature. J Sleep Res 4:212–228PubMedGoogle Scholar
  48. Pivik RT, Broughton RJ, Coppola R, Davidson RJ, Fox N, Nuwer MR (1993) Guideline for the recording and quantitative analysis of electroencephalographic activity in research context. Psychophysiology 30:547–558PubMedGoogle Scholar
  49. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. US Government Printing Office, Washington D.C., USAGoogle Scholar
  50. Saletu B, Grunberger J, Linzmayer K, Stohr H (1986) Pharmaco-EEG, psychometric and plasma levels studies with two novel alpha-adrenergic stimulants CRL 40476 and 40028 (adrafinil) in elderlies. In: Pancheri P (ed) News trends in experimental and clinical psychiatry, Rome, p 5631Google Scholar
  51. Saletu B, Barbanoj MJ, Anderer P, Sieghart W, Grunberger J (1993a) Clinical-pharmacological study with two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation. Meth Find Exp Clin Pharmacol 15:291–312Google Scholar
  52. Saletu B, Saletu M, Grunberger J, Frey R, Anderer P, Mader R (1993b) Treatment of the alcoholic organic brain syndrome: double-blind, placebo-controlled clinical, psychometric and electroencephalographic mapping studies with modafinil. Neuropsychobiology 27:26–39PubMedGoogle Scholar
  53. Santamaria J, Chiappa KH (1987) The EEG of drowsiness in normal adults. J Clin Neurophysiol 4:327–382PubMedGoogle Scholar
  54. Scammell TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS, Saper CB (2000) Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 20:8620–8628PubMedGoogle Scholar
  55. Slattum PW, Venitz J, Carr WH (1996) Comparison of methods for the assessment of central nervous system stimulant response after dextroamphetamine administration in healthy male volunteers. J Clin Pharmacol 36:1039–1050PubMedGoogle Scholar
  56. Stampi C, Stone P, Michimori A (1993) The alpha attenuation test: a new quantitative method for assessing sleepiness and its relationship to the MSLT. J Sleep Res 22:115Google Scholar
  57. Steriade M, Gloor P, Llinas RR, Lopes da Silva FH, Mesulam MM (1990) Basic mechanisms of cerebral rhythmic activities. Report of IFCN Committee on Basic Mechanism. Electroencephalogr Clin Neurophysiol 76:481–508PubMedGoogle Scholar
  58. Tanganelli S, Perez de la Mora M, Ferraro L, Mendez-Franco J, Beani L, Rambert FA, Fuxe K (1995) Modafinil and cortical gamma-aminobutyric acid outflow. Modulation by 5- hydroxytryptamine neurotoxins. Eur J Pharmacol 273:63–71PubMedGoogle Scholar
  59. Warot D, Corruble E, Payan C, Weil JS, Puech AJ (1993) Subjective effects of modafinil, a new central adrenergic stimulant in healthy volunteers: a comparison with amphetamine, caffeine and placebo. Eur J Psychiatry 8:201–208Google Scholar
  60. Wesensten NJ, Belenky G, Kautz MA, Thorne DR, Reichardt RM, Balkin TJ (2002) Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine. Psychopharmacology 159:238–247Google Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Florian Chapotot
    • 1
  • Ross Pigeau
    • 2
  • Frédéric Canini
    • 1
  • Lionel Bourdon
    • 1
  • Alain Buguet
    • 3
  1. 1.Département des Facteurs HumainCentre de Recherches du Service de Santé des ArméesLa Tronche CedexFrance
  2. 2.Command Effectiveness and Behavior SectionDefence Research and Development CanadaTorontoCanada
  3. 3.Institut de Médecine Tropicale du Service de Santé des ArméesMarseilleFrance

Personalised recommendations